|
Documents
|
| Booster effectiveness |
721KB |
Approved |
8 Months Ago |
8 Months Ago |
|
| Effectiveness of BNT162b2 COVID-19 booster vaccine |
527KB |
Approved |
8 Months Ago |
7 Months Ago |
|
| Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England |
465KB |
Approved |
12 Months Ago |
11 Months Ago |
|
| Mitigation of risks of COVID-19 in occupational settings with a focus on ethnic minority groups |
269KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Weekly all-cause mortality surveillance week 19 report |
178KB |
Approved |
3 Months Ago |
3 Months Ago |
|
| Effectiveness of 3 doses of COVID-19 vaccines against symptomatic COVID-19 and hospitalisation in adults aged 65 years and older |
150KB |
Approved |
7 Months Ago |
7 Months Ago |
|
| Letter of invitation for Respiratory Evidence Panel - individual and group |
144KB |
Approved |
10 Months Ago |
10 Months Ago |
|
| Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England |
135KB |
Approved |
3 Months Ago |
3 Months Ago |
|
| SARS-CoV-2 variant under investigation, meeting minutes |
91KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| DCT SOP Module Version Control |
19KB |
Approved |
5 Months Ago |
5 Months Ago |
|
| Confirmed_Omicron_cases_LTLA_2021-12-23.csv |
5KB |
Approved |
7 Months Ago |
7 Months Ago |
|
|
|
|
|
|
|